Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5376120 | 0.82 | MAPK1 (0.47) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL9296363 | 0.76 | MAPK1 (0.42) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL31236759 | 0.76 | MAPK1 (0.42) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL9075196 | 0.76 | MAPK1 (0.42) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL17183628 | 0.76 | MEN1 (0.42) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3025090 | 0.75 | MEN1 (0.39) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL31571666 | 0.75 | MEN1 (0.39) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL779664 | 0.75 | MEN1 (0.49) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL58539 | 0.74 | MAPK1 (0.57) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3406520 | 0.73 | MEN1 (0.47) | MAPK1MEN1KMT2AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820382-A | Asymmetric binuclear nickel complex containing heteroligand and preparation method and application thereof | 中国神华煤制油化工有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117820383-A | Asymmetric acenaphthenyl alpha-diimine nickel complex containing amino and preparation method and application thereof | 中国神华煤制油化工有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-107466322-A | Saltant type transaminase and relative method and purposes | 豪夫迈·罗氏有限公司 | 2017-12-12 | — | — | CN | claimed |
| US-4055546-A | REACTION OF A PHENOLIC RESIN WITH AN ORGANIC SILICATE | HITACHI CHEMICAL COMPANY, LTD. (JA) | 1977-10-25 | — | — | US | claimed |
| CN-117820383-A | Asymmetric acenaphthenyl alpha-diimine nickel complex containing amino and preparation method and application thereof | 中国神华煤制油化工有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117820382-A | Asymmetric binuclear nickel complex containing heteroligand and preparation method and application thereof | 中国神华煤制油化工有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-11702557-B2 | Ink composition for manufacturing organic semiconductor device | DAICEL CORPORATION (JP) | 2023-07-18 | — | — | US | disclosed |
| EP-3958335-A1 | INK COMPOSITION FOR PRODUCING ORGANIC SEMICONDUCTOR DEVICE | Daicel Corporation (JP) | 2022-02-23 | — | — | EP | disclosed |
| US-11126084-B2 | Composition for resist underlayer film formation, resist underlayer film and forming method thereof, production method of patterned substrate, and compound | JSR CORPORATION (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20210246325-A1 | INK COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | DAICEL CORPORATION (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3855520-A1 | INK COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | Daicel Corporation (JP) | 2021-07-28 | — | — | EP | disclosed |
| CN-108008600-B | Radiation-sensitive composition | 三菱瓦斯化学株式会社 | 2021-02-09 | — | — | CN | disclosed |
| US-5622960-A | ANTICANCER, ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
| US-5606060-A | ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1997-02-25 | — | — | US | disclosed |
| WO-1996030395-A2 | CYSTEINE PROTEASE INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-03 | — | — | WO | disclosed |
| EP-0665846-A1 | TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREFOR | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994010175-A1 | TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREFOR | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) | 1994-05-11 | — | — | WO | disclosed |
| EP-0041675-B1 | 4-HALOGEN-5-(TRICHLOROMETHYL-PHENYL)-OXAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND RADIATION-SENSITIVE COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-12-11 | — | — | EP | disclosed |
| US-4371607-A | 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-01 | — | — | US | disclosed |
| EP-0041675-A2 | 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11126084-B2 | Composition for resist underlayer film formation, resist underlayer film and forming method thereof, production method of patterned substrate, and compound | EMG1, FN1, TOP1 | MAPK1 2804/4885MEN1 115/4885KMT2A 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.